The 10 Best Stocks for a Year-End Momentum Trade - Nov 12

Share this article
Spread the word on social media
The Big Picture
A year-end momentum trade may have a seasonal tailwind, but the available information doesn't identify the 10 stocks behind the idea. For your portfolio, that means the headline is a starting point for research, not a complete stock screen or a basis for comparing candidates.
The MarketWatch summary says December is the best month of the year for momentum strategies. No current stock prices, today's moves, performance figures, or full list of companies are included in the supplied material, so there's no way to assess how the named stocks are trading now.
What's Happening
The reported thesis is seasonal: December has historically been favorable for momentum approaches, according to the source summary. That claim may interest investors evaluating a short-term strategy, but the summary doesn't provide the historical period, return figures, benchmark, or methodology needed to test it.
The additional data contains several figures, but no labels connect them to a company, financial statement, valuation measure, or forecast. They can't be responsibly treated as growth rates, earnings, sales, or returns without that context.
- 5.3% is provided, but its metric, company, and reporting period aren't identified.
- 5.2% is also provided without an associated stock or explanation.
- $239.4b appears in the context, but the underlying measure and issuer aren't specified.
- $2.2b is listed without a corresponding company, period, or financial category.
- Tenaris S.A. ($TS) is described as a steel products company and is reported to have a Zacks Rank #1. The note that follows, about what it “witnessed,” is cut off at “Zacks Consens,” so the relevant estimate or change can't be established.
Those gaps matter if you're comparing momentum candidates. A percentage without a label cannot be checked against expectations or past results, and dollar figures without an issuer or time period aren't useful for a valuation comparison. The provided material doesn't include analyst price targets, earnings estimates, or a complete set of financial results.
Why It Matters For Your Portfolio
Momentum strategies focus on stocks showing relative price strength, while the source summary's seasonal point suggests December may be worth examining. But the material here doesn't provide individual stock performance or evidence that any particular company has momentum today. You'd need to verify the actual list and each stock's recent price trend before drawing a portfolio conclusion.
Short-term traders may care most about current price action and upcoming company-specific catalysts. Growth and value investors may instead want earnings, cash flow, and valuation measures to judge whether a move is supported by fundamentals. For $TS, the Zacks Rank #1 is one reported data point, but the incomplete consensus detail and absence of valuation or price information make it insufficient on its own. No analyst sentiment beyond that rank is supplied.
Risks To Consider
Seasonality isn't a guarantee. The source summary gives no historical sample or evidence about how consistently December's reported momentum advantage has occurred, so the claim shouldn't be treated as a forecast.
The missing stock list and market data create a selection risk. Without names, current prices, or performance, you can't tell whether a candidate's momentum is continuing, fading, or already reflected in its price.
The Tenaris catalyst is unclear. The supplied note ends mid-sentence, and the unlabelled figures can't be tied to $TS or another company. If the incomplete information conceals a negative revision or a different metric than expected, the investment interpretation could change.
The bear case is straightforward: a seasonal strategy may fail to deliver, and an investor acting on an incomplete list could select stocks without confirming their business performance, valuation, or near-term risks.
What To Watch Next
The first step is to obtain the complete list and verify the source's underlying figures. The supplied material gives no dates for company reports or other scheduled events, and it doesn't specify a share-price level to monitor. Avoid treating an unverified catalyst as imminent.
Check the full MarketWatch article for the identities of all 10 stocks and the method used to select them.
For each candidate, compare current price action with the reported momentum thesis, and review the time period and benchmark behind any performance claim.
For $TS, seek the complete Zacks consensus statement and verify what changed, if anything. The available note doesn't specify the underlying estimates or timing.
Confirm what 5.3%, 5.2%, $239.4b, and $2.2b measure before using them in valuation or company comparisons.
These checks can help you distinguish a broad seasonal idea from a company-specific setup. Until the missing details are available, there are no supported entry levels or price targets to report.
The Bottom Line
The source summary presents December as a favorable month for momentum strategies, but it supplies no supporting historical figures.
The 10 stocks aren't named in the material provided, and current prices and today's moves aren't available.
$TS has a reported Zacks Rank #1, but its consensus-related catalyst note is incomplete.
The four financial figures lack labels and shouldn't be used as valuation inputs until their meaning is confirmed.
This is informational, not a buy, sell, or hold recommendation. Consider waiting for the full stock list and verifying company-specific data before evaluating any trade.
FAQ
Q: Which 10 stocks are included in the year-end momentum trade?
A: The available source summary doesn't name them. Check the full source article before relying on any list.
Q: Does the information confirm that December momentum will continue?
A: No. The summary describes December as the best month for momentum strategies, but provides no historical returns, methodology, or guarantee of future performance.
Q: What is the Tenaris ($TS) catalyst?
A: The context reports a Zacks Rank #1 and an incomplete reference to “Zacks Consens.” It doesn't provide enough detail to identify the specific consensus measure or catalyst.